Release Date: 30/04/10 14:57 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 57.49KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%